The DOI matches its Crossref record.
PR-39, a proline-rich antibacterial peptide that inhibits phagocyte NADPH oxidase activity by binding to Src homology 3 domains of p47 phox.
Open accessAbstract
Reactive oxygen intermediates generated by the phagocyte NADPH oxidase are critically important components of host defense. However, these highly toxic oxidants can cause significant tissue injury during inflammation; thus, it is essential that their generation and inactivation are tightly regulated. We show here that an endogenous proline-arginine (PR)-rich antibacterial peptide, PR-39, inhibits NADPH oxidase activity by blocking assembly of this enzyme through interactions with Src homology 3 domains of a cytosolic component. This neutrophil-derived peptide inhibited oxygen-dependent microbicidal activity of neutrophils in whole cells and in a cell-free assay of NADPH oxidase. Both oxidase inhibitory and direct antimicrobial activities were defined within the amino-terminal 26 residues of PR-39. Oxidase inhibition was attributed to binding of PR-39 to the p47phox cytosolic oxidase component. Its effects involve both a polybasic amino-terminal segment and a proline-rich core region of PR-39 that binds to the p47phox Src homology 3 domains and, thereby, inhibits interaction with the small subunit of cytochrome b558, p22phox. These findings suggest that PR-39, which has been shown to be involved in tissue repair processes, is a multifunctional peptide that can regulate NADPH oxidase production of superoxide anion O2-. thus limiting excessive tissue damage during inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Babior, B. M. (1999) · Blood · doi:10.1182/blood.v93.5.1464 · Cited by 2,134
LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
Krause, A., Neitz, S., Mägert, H.-J., Schulz, A., Forssmann, W.-G., Schulz-Knappe, P., & Adermann, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01920-7 · Cited by 1,324
Kay, B. K., Williamson, M. P., & Sudol, M. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.2.231 · Cited by 1,215
Innate antimicrobial peptide protects the skin from invasive bacterial infection
Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., Dorschner, R. A., Pestonjamasp, V., Piraino, J., Huttner, K., & Gallo, R. L. (2001) · Nature · doi:10.1038/35106587 · Cited by 1,198
Antibacterial peptides: basic facts and emerging concepts
Boman, H. G. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01228.x · Cited by 1,158
Cathelicidins, multifunctional peptides of the innate immunity
Zanetti, M. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0403147 · Cited by 988
“PR-39 inhibits NADPH oxidase by blocking assembly via interaction with SH3 domains, which are present in the cytosolic subunit p47 and are responsible for its interaction with the membrane component p22 [115].”
BackgroundCombating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets
Drummond, G. R., Selemidis, S., Griendling, K. K., & Sobey, C. G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3403 · Cited by 899
Genetic, Biochemical, and Clinical Features of Chronic Granulomatous Disease
Segal, B. H., Leto, T. L., Gallin, J. I., Malech, H. L., & Holland, S. M. (2000) · Medicine · doi:10.1097/00005792-200005000-00004 · Cited by 883
Self-citationThe vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases
Cai, H., Griendling, K. K., & Harrison, D. G. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00233-5 · Cited by 687
Loss of Function of a Proline-Containing Protein Confers Durable Disease Resistance in Rice
Fukuoka, S., Saka, N., Koga, H., Ono, K., Shimizu, T., Ebana, K., Hayashi, N., Takahashi, A., Hirochika, H., Okuno, K., et al. (2009) · Science · doi:10.1126/science.1175550 · Cited by 678
Yang, D., Biragyn, A., Hoover, D. M., Lubkowski, J., & Oppenheim, J. J. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104603 · Cited by 572
Dorschner, R. A., Pestonjamasp, V. K., Tamakuwala, S., Ohtake, T., Rudisill, J., Nizet, V., Agerberth, B., Gudmundsson, G. H., & Gallo, R. L. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01340.x · Cited by 567
The Role of Cathelicidins in the Innate Host Defenses of Mammals
(2005) · Current Issues in Molecular Biology · doi:10.21775/cimb.007.179 · Cited by 393
PR39, a peptide regulator of angiogenesis
Li, J., Post, M., Volk, R., Gao, Y., Li, M., Metais, C., Sato, K., Tsai, J., Aird, W., Rosenberg, R. D., et al. (2000) · Nature Medicine · doi:10.1038/71527 · Cited by 386
Antimicrobial peptides of vertebrates
Ganz, T., & Lehrer, R. I. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80029-0 · Cited by 378
Biology and clinical relevance of naturally occurring antimicrobial peptides
Gallo, R. L., Murakami, M., Ohtake, T., & Zaiou, M. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.129801 · Cited by 291
Structural features and biological activities of the cathelicidin-derived antimicrobial peptides
Gennaro, R., & Zanetti, M. (2000) · Biopolymers · doi:10.1002/1097-0282(2000)55:1<31::aid-bip40>3.0.co;2-9 · Cited by 291
Regulation and termination of NADPH oxidase activity
DeCoursey, T. E., & Ligeti, E. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5177-1 · Cited by 268
Cathelicidins: microbicidal activity, mechanisms of action, and roles in innate immunity
Ramanathan, B., Davis, E. G., Ross, C. R., & Blecha, F. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)01549-6 · Cited by 268
Self-citationEndothelial NADPH Oxidase as the Source of Oxidants in Lungs Exposed to Ischemia or High K +
Al-Mehdi, A. B., Zhao, G., Dodia, C., Tozawa, K., Costa, K., Muzykantov, V., Ross, C., Blecha, F., Dinauer, M., & Fisher, A. B. (1998) · Circulation Research · doi:10.1161/01.res.83.7.730 · Cited by 265
Self-citationBarchowsky, A., Klei, L. R., Dudek, E. J., Swartz, H. M., & James, P. E. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00186-0 · Cited by 259
Cathelicidins: Immunomodulatory Antimicrobials
Van Harten, R. M., Van Woudenbergh, E., Van Dijk, A., & Haagsman, H. P. (2018) · Vaccines · doi:10.3390/vaccines6030063 · Cited by 258
Nox enzymes as novel targets for drug development
Lambeth, J. D., Krause, K.-H., & Clark, R. A. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0123-6 · Cited by 212
Cole, A. M., Shi, J., Ceccarelli, A., Kim, Y.-H., Park, A., & Ganz, T. (2001) · Blood · doi:10.1182/blood.v97.1.297 · Cited by 146
Self-citationNox2 B-loop peptide, Nox2ds, specifically inhibits the NADPH oxidase Nox2
Csányi, G., Cifuentes-Pagano, E., Al Ghouleh, I., Ranayhossaini, D. J., Egaña, L., Lopes, L. R., Jackson, H. M., Kelley, E. E., & Pagano, P. J. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.04.025 · Cited by 131
“Previously, the peptide-based inhibitor PR-39, which binds to the SH3 domains of p47, was shown to prevent association of p47 with Nox2 [41,42].”
Nox1, 2, 4, 5: Counting out oxidative stress
Wingler, K., Hermans, J., Schiffers, P., Moens, A., Paul, M., & Schmidt, H. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01249.x · Cited by 113
“A more reliable tool to inhibit NADPH oxidases are cellpermeable peptide-based inhibitors such as gp91ds-tat (Rey et al., 2001), whereas another peptide inhibitor, the naturally occurring peptide PR-39 (Gudmundsson et al., 1995; Shi et al., 1996), is rather unspecific as it binds to SH3 domains of many proteins (Cai e…”
The Quest for Selective Nox Inhibitors and Therapeutics: Challenges, Triumphs and Pitfalls
Cifuentes-Pagano, E., Meijles, D. N., & Pagano, P. J. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5620 · Cited by 84
Inhibition of human vascular nadph oxidase by apocynin derived oligophenols
Mora-Pale, M., Weïwer, M., Yu, J., Linhardt, R. J., & Dordick, J. S. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.05.061 · Cited by 36
Metadata
- Authors
- Shi, J., Ross, C. R., Leto, T. L., & Blecha, F.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1996-06-11
- Volume
- 93
- Issue
- 12
- Pages
- 6014-6018
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2027074022
- Cited by
- 185
- References
- 0
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.